Patents expiring in 2036

US 9440967

1H-pyrrolo [2, 3 -B] pyridine derivatives and their use as radical quenchers

ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Tue Sep 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9440056

Device and method for dispensing a drug

Demira, Inc. · Granted Tue Sep 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9439889

Methods employing wolbachia FtsZ as a target for albendazole sulfone

The Regents of the University of California · Granted Tue Sep 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9439888

Tetrazolones as a carboxylic acid bioisosteres

Rigel Pharmaceuticals, Inc. · Granted Tue Sep 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9439958

Stabilized virus like particles having enhanced mucosal immunogenicity

ARIZONA BOARD OF REGENTS, ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Tue Sep 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9439928

Method for combined conditioning and chemoselection in a single cycle

The Regents of the University of California · Granted Tue Sep 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9439875

Anxiolytic effect of pterostilbene

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Sep 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9439984

Macrocycles

The Regents of the University of California · Granted Tue Sep 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9439948

Degradable cage coated with mineral layers for spinal interbody fusion

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Sep 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9439976

Compositions and methods for using cathepsin E cleavable substrates

The Board of Regents of the University of Texas System · Granted Tue Sep 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9439979

Epidermal growth factor receptor (EGFR) and methods of use in adenoviral-associated virus type 6 (AAV6) transduction

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Sep 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

EP 3067050

TRANSDERMALES THERAPEUTISCHES SYSTEM MIT EINEM OVERTAPE MIT ZWEI HAFTSCHICHTEN

ACINO AG [DE] · Granted Wed Sep 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue Sep 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9445870

Methods and devices for crosslinking of corneal collagen and for treatment of disorders of the eye

Montefiore Medical Center · Granted Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9446028

Methods of increasing tonic inhibition and treating fragile X syndrome and angelman syndrome

OVID THERAPEUTICS INC. · Granted Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9446010

Compounds and methods for treating aberrant adrenocortical cell disorders

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9446022

Pro-neurogenic compounds

The Board of Regents of the University of Texas System · Granted Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9446021

Derivatives of fluorene, anthracene, xanthene, dibenzosuberone and acridine and uses thereof

Dogwood Pharmaceuticals, Inc. · Granted Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9446038

Method and composition for treating a serotonin receptor-mediated condition

VANDA PHARMACEUTICALS INC. · Granted Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9446037

Methods for the treatment of parkinson's disease psychosis using pimavanserin

ACADIA Pharmaceuticals Inc. · Granted Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9446042

Pro-neurogenic compounds

The Board of Regents of the University of Texas System · Granted Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9446048

Methods for treating leukemia and disorders mediated by CBFβ and RUNX1 proteins

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9446067

Mercapto-modified biocompatible macromolecule derivatives with low degree of mercapto-modification and the cross-linked materials and uses thereof

BIOREGEN BIOMEDICAL (CHANGZHOU) CO., LTD. · Granted Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9446072

Methods of ameliorating oxidative stress by increasing the efficiency of GPX and SOD activity

Reoxcyn Discoveries Group, Inc. · Granted Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9446068

Method of production of the stable selenium-comprising pharmaceutical composition with a high selenium level

OBSCHESTVOS S OGRANITCHENNOI OTVETSTVENNOSTJU “OXYGON” · Granted Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9446080

Compositions and methods

Seres Therapeutics, Inc. · Granted Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9446107

Scaffolds for cell transplantation

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9446112

Clostridium difficile DNA vaccine

Inovio Pharmaceuticals, Inc. · Granted Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9446121

Cloning of honey bee allergen

PLS-Design GmbH · Granted Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9447100

Substituted pyrazolo[1,5-A] pyrimidines as calcium receptor modulating agents

Takeda Pharmaceutical Company Limited · Granted Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9446125

Anti-EphA2 antibodies and methods of use thereof

THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, BERKE · Granted Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9446139

Polymer-based compositions and conjugates of HIV entry inhibitors

Nektar Therapeutics · Granted Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9447047

Inhibitors of protein phosphatase-1 and uses thereof

The Board of Regents of the University of Texas System · Granted Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9447155

Isoform Nell-1 peptide

The Regents of the University of California · Granted Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9447376

Dried spore germinative compound mixtures

Envera, LLC · Granted Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9447390

Aldehyde tags, uses thereof in site-specific protein modification

The Regents of the University of California · Granted Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9447401

PH20 polypeptide variants, formulations and uses thereof

HALOZYME, INC. · Granted Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9447405

Regulation of specific spinal neurons regulating pain transmission via chimeric toxins

The Regents of the University of California · Granted Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9447416

Multiple exon skipping compositions for DMD

Sarepta Therapeutics, Inc. · Granted Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9447419

RNAi-mediated inhibition of tumor necrosis factor α-related conditions

Arrowhead Pharmaceuticals, Inc. · Granted Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9447468

Compounds that modulate oxidative stress

VTV THERAPEUTICS LLC · Granted Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9447417

Multiple exon skipping compositions for DMD

Sarepta Therapeutics, Inc. · Granted Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9446036

Compositions of a polyorthoester and an aprotic solvent

Heron Therapeutics, Inc. · Granted Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9446075

Compositions derived from stem cell released molecules and methods for formulation thereof

BIOREGENERATIVE SCIENCES, INC. · Granted Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9446114

Cross-protective arenavirus vaccines and their method of use

Inovio Pharmaceuticals, Inc. · Granted Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9447144

MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9447173

Human antibodies to respiratory syncytial virus F protein and methods of use thereof

REGENERON PHARMACEUTICALS, INC. · Granted Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9447406

Chemically modified cystathionine beta-synthase enzyme for treatment of homocystinuria

The Regents of the University of Colorado, a Body Corporate · Granted Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9453019

Linked purine pterin HPPK inhibitors useful as antibacterial agents

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Sep 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)